FDA Records Show Significant Number of mRNA Test Rats Born with Skeletal Deformations – Judicial Watch
Judicial Watch announced today that it received 699 pages of records from the Department of Health and Human Services (HHS) regarding data Moderna submitted to the Food and Drug Administration (FDA) on its mRNA COVID-19 vaccine, which indicate a “statistically significant” number of rats were born with skeletal deformations after their mothers were injected with the vaccine. The documents also reveal Moderna elected not to conduct a number of standard pharmacological studies on the laboratory test animals.
Judicial Watch obtained the records through a September 2021 Freedom of Information Act (FOIA) lawsuit filed after the FDA, the Centers for Disease Control and Prevention (CDC) and the National Institute for Allergy and Infectious Disease (NIAID) failed to respond to a June 2021, FOIA request biodistribution studies and related data for the Pfizer, Moderna and Johnson& Johnson COVID vaccines (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:21-cv-02418)).
The records include a “Nonclinical Overview” prepared by Moderna and submitted to the FDA for approval of its vaccine revealing that a number of rats were born with skeletal deformations, known as “wavy ribs” and “rib nodules,” to mothers injected with the mRNA vaccine. The study dismissed the anomalies as “not considered adverse:”
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
mRNA-1273-related variations in skeletal examination included statistically significant increases in the number of F1 rats with 1 or more wavy ribs and 1 or more rib nodules. Wavy ribs appeared in 6 fetuses and 4 litters with a fetal prevalence of 4.03% and a litter prevalence of 18.2%. Rib nodules appeared in 5 of those 6 fetuses. Skeletal variations are structural changes that do not impact development or function of a developing embryo, are considered reversible, and often correlate with maternal toxicity and/or lack of other indicators of developmental toxicity (Carney and Kimmel 2007). Maternal toxicity in the form of clinical observations was observed for 5 days following the last dose (GD 13), correlating with the most sensitive period for rib development in rats (GDs 14 to 17). Furthermore, there were no other indicators of mRNA-1273-related developmental toxicity observed, including delayed ossification; therefore, these common skeletal variations were not considered adverse.
(Non-adverse deformations receive a different perspective in the July 2009 Environmental Researcharticle, “Dose–response relationships of rat fetal skeleton variations: Relevance for risk assessment:”
